0001144204-11-033738.txt : 20110602 0001144204-11-033738.hdr.sgml : 20110602 20110602170826 ACCESSION NUMBER: 0001144204-11-033738 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20110602 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20110602 DATE AS OF CHANGE: 20110602 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BRAINSTORM CELL THERAPEUTICS INC CENTRAL INDEX KEY: 0001137883 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 912061050 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-54365 FILM NUMBER: 11889262 BUSINESS ADDRESS: STREET 1: 110 EAST 59TH STREET CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 250-519-0553 MAIL ADDRESS: STREET 1: 110 EAST 59TH STREET CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: GOLDEN HAND RESOURCES INC DATE OF NAME CHANGE: 20030827 FORMER COMPANY: FORMER CONFORMED NAME: WIZBANG TECHNOLOGIES INC DATE OF NAME CHANGE: 20010409 8-K 1 v224823_8k.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  June 2, 2011

Brainstorm Cell Therapeutics Inc.
(Exact name of registrant as specified in its charter)

Delaware
    
333-61610
    
20-8133057
(State or other jurisdiction of incorporation)
    
(Commission File No.)
    
(IRS Employer Identification No.)
 
605 Third Avenue, 34th Floor
  
New York, NY
10158
(Address of principal executive offices)
(Zip Code)

(212) 557-7200
(Registrant’s telephone number, including area code)

N/A
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
  
 
 
 
 
Item 8.01  Other Events
 
On June 2, 2011, Brainstorm Cell Therapeutics Inc. (the “Company”) issued a press release announcing that it intends to adjourn its Annual Meeting of Stockholders to Friday, June 10, 2011, at 9:00 a.m., New York City time at the offices of the Company at 605 Third Avenue, 34th Floor, New York, New York 10158. A copy of the press release issued by the Company concerning the foregoing is included herewith as Exhibit 99.1 and is incorporated herein by reference.
 
Item 9.01  Financial Statements and Exhibits
 
(d) Exhibits
 
The exhibit listed in the Exhibit Index below is filed with this report.
 
 
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

June 2, 2011
Brainstorm Cell Therapeutics Inc.
 
 
 
 
By:  
/s/ Liat Sossover
   
Liat Sossover
 
Chief Financial Officer
 
 
 
 
 
EXHIBIT INDEX
 
Exhibit
No.
  
Description
99.1
  
Press Release dated June 2, 2011

 
 
 
EX-99.1 2 v224823_ex99-1.htm
 
BrainStorm Intends to Adjourn Annual Meeting of Stockholders until June 10, 2011
 
NEW YORK & PETACH TIKVAH, Israel—(BUSINESS WIRE)— BrainStorm Cell Therapeutics Inc. (OTCBB:BCLI), a leading developer of adult stem cell technologies and therapeutics announced today that, immediately upon convening its Annual Meeting of Stockholders on Thursday, June 9, 2011, the Company intends to adjourn the meeting to Friday, June 10, 2011, at 9 a.m., New York City time, to be held at the Company’s offices located at 605 Third Avenue, 34th Floor, New York, New York 10158. The Company is taking this action due to a religious holiday on Thursday, June 9, 2011.
 
About BrainStorm Cell Therapeutics Inc.
 
BrainStorm Cell Therapeutics Inc. is a promising company developing adult stem cell therapeutic products, derived from autologous (self) bone marrow cells, for the treatment of neurodegenerative diseases. The Company holds rights to develop and commercialize the technology through an exclusive, worldwide licensing agreement with Ramot at Tel Aviv University Ltd., the technology transfer company of Tel-Aviv University. For more information, visit the company’s website at www.brainstorm-cell.com.

Contacts
BrainStorm Cell Therapeutics
Dr. Adrian Harel, acting CEO
Phone: +972-3-9236384
Email: aharel@brainstorm-cell.com

Source: BrainStorm Cell Therapeutics
 
 
 
 
 
 GRAPHIC 3 logo.jpg GRAPHIC begin 644 logo.jpg M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$" M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,# M`P,#`P,#`P,#_\``$0@`10#E`P$1``(1`0,1`?_$`+@``0`!!`,!`0`````` M```````)`0('"`,&"@4$`0$```6-U8I$I+]0;+343E&&,G<@,3X@A7L[?+C$PC!B0XG$[E$[E=4A!-] M*R;%$3N78^9`\`\1#5.GG_.O\JD29.R1IU$'+'2J>F,AHMKWRO`?*E3-',M( M"<\E3NB`CD=_Y"6/J+9G-7Q;07EL%NKZ172DHFP,N('[04,X.U>(H$4*'\@% M,8/CK=FT>D5XOM*9U>1*"?AQ]T>*]LE;;']2CWIEV]T:X+>]CFZ^^EVU&%K< M,ON8"LI=_(RJ:2IMB@)O19HJ"4!W[@('YZN];T3DTDMX\PNGM'Q%5Y\>64:W MNE^FUP-11-+"[((B($_QC/E'YZYX5:MYVI7F6=$`I5UH67:EE8T``Y>\BK=5 M%-4B9@#;<%B[;ZY=WI8]W[=JW/MXF.IFN*^$D:4[HUY.O6[[?.-5XWTXX-!= MVJ0!DD29\?OOJ#M.SY[9&YV.8-0:7$$#-"5*#MC96S-U-W(PR:AA94MY@A3W)GR` MB2F*FXV<9(R$2\0>M'!`43504(H':(`(%,!1,)1$!WZZWCMK=MAWK9VW3:U3 M)JJ50#I>UQ'8Y"4/88S:=)FR4\UKF]X(]X$?73,`E#J`]1^'Q'X:RH:`=+4' M8(HE8OU-$(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0 MCC./:`CMO^'QU!-3@T_#%.8[RVE[?BB.OG5S(A^/%95A(Y,9]ONZT&VI)D MVXC6UA:@[B(W&Q1_X[U>OTLTLF7+[/U2LI&(LG&P":'ZJG52["9RX5D&RB,2 MV7.`[=#*=H]`#6Q:CKE.MM(:6STK&S$[`!Z?L]T<@WHNOE3Y]1E$S&'_`&HN M#6&(MLP@L,1UB>(`3U)F[R,G9I!,45#+&@L!0=L;*1_%'C[#?-`XPK<&<`[2#%MU&R10W`1+ M]-ZAFPE-ML("0>FL=GWR[5,MTNLG%\MX0@\8.I:9S',E-TZ@A[HPWE3A#19E M(\]C-JVJ-O;%,H"*0>C"3.VQA0=H$*8&JAQ#HH0`'?QZ:YMZR]"[)U0L4RDE M!LJX>6_03EK+3I./^I.R/%16:FM/6 M.UE(ER)A`"H!U6;]WBV4`G<0_@(:^2NR]X]5/H[ZQ"U[@US=I3Y@ESI9_EN4 MIJ;D"F8(*\HWYMZWT^][9\M4?_2:,.8,20X_O<'D&O,[%`N4W+5?^FMV;"*# M@G11(X`(["7^`Z^WNS=U6#>MCD[@V_,$REGLUCF"V;H;? M<&EHP(7BTC`QWHH[^7Q#^WPUDLIVL%Q^)4BRNP=I_"D7ZJPAI"&D(:0AI"&D M(:0AI"&D(X@./Q`/S`1_9TZ:D28BE!$`)AX((KW#\0_>&HZC^ZZ)T[#%X=0U M,"N*)$IBND(:0AI"&D(:0AI"&D(^+.R2,-%RF/\H;F_'7'&TKO67WJ MTV[5;S,9YNG@`)8=@$"#/CG'V0J-B2>DG0-D]@;)FNH6N=Q+ICD)/B7,>B/4 M5P\X]T#COCII3X2-:+6J4^GD[M-`BF9V]EU2BH5BH?J8K6(2,"9"_P`@#N.V MXCKM>MW#\Y5N8R9J:P`($PR'"/D[NJYW&[W&=6S'.%&IT@X#',]JXQNB!"AM ML`!L&P;=``/@`>``&VJ1\6)6,*7A%AC=H^6W3J/=_'PU*6@X(X]Q_P`8AJEC M!RKW1;OOY;_L$0_CJBZ2UQ!TN4'BX_?$=;R8TEKO*'B+ M3I(#\$Q<">1C8?3:\"R[NI#.8>'36B/H$ZL5E:V;LNX3BZGDAS);2&A"# MCB`"?$N:QU?]2O3^GN>R:7>]KE`3Z<#SW@GQ,/P*%0:0F0';$X:1AW$!'<=N MX>FP;CMY[:^IZ,:=+1XLS'!LOS-(\TJXA1V#E'/J,5(:0AI"&D(:0AI"&D(: M0AI"("T/=^SY>[ME*OX`]O?-6<:OBO(Q08)*/F8IRDJQ=) MJ)I+D,/R"78P==;LJNEFW[1)IGWNZRY,^HE:P"'8=F7/#E&!/W)YOSNV^;VCN2@E`!$0"5HYNA0W$.MC+L.WA\1UY?T)LW`?GL@ MD]^'?X8]RA&- MHRR1D-/'5+$S+(6[MTVDHIT*6Q5DS`&X^>L:WEL>=M9DNMD5$JLM4\*R;+5# MS"GM7'+A%SM-[9<'>0YKQ.&9(3V'$>F)&.\>GR]1\0W`!#]X]=:];.:YR"+^ M_4WX1JBHGV\AU4!!PXQ$#GG`#[^0AJFH->'89&)`7*A""+552I$,H?H4I3&,/D4I0W,(_@`:G`)(`S,3' M`+'4*=D*F9!;2+VE62&M#*(E'T%)NX21:R*#&;C%?0D8EV=JHH"$@R5V!1,V MQBB(;ZK5U+5V^89=5+5\M(1''C+[V+$Y9' M]$2Z#`2!N8'+E(&R8``"`]PBIK`NH$Y\G9-?/EE'NDX=B@1LKI'3LKNJ5EI9 MB-EFK:23E@Z//I[3?$5O1Y;*?)?(:"CA_58!\Y@4'R)133DWQEW"SXP#W;JI M!N!1WZ";7,W1JW.IJ&OW5=2V71R)#O$XY.#E5?9Z8^BGU?=39EU_*.G%C>=, MV=+:_206EN@*$&.<3K\9;6O;T):466%P?O[^\0V$>\YA$=AZ_P`HZV)T8W)4 M;EN=75/691ESD.H'2BHH5<>$<.]7K(VRMD44F69+RUJKQ1%RYQMC)23:+8.Y M%V;TVK%LX=N%!$H=B#9(RRQ]S"!0[$RB/40#IKHVG8^IJ&TTL'S7D`=Y*"-$ M5,]E+*,V9D(A#>>[SDO(,U8%>*'`SD'R6QW7YZ7K0Y7JK.#B:9,2\$\/'RS: M`>S4XP6E2LGJ1DSJIIBGW%$`$=M;9_MS;+=*:V_W.33USF@F7D6J%"J#P3'( M\(P^;NBL>\_)R5I^!.)[(;;^T=R7VWZB67I.P;`(_-_W&8>OD M``(B/34[=D;.\*WN2"XIDJ=I1L1D[BN,FS.+?N?M;HC\HL_36.!Q5#?;8->FY]% M:\7&FD6N<*JAGI_%:?"`2,4.8`B#MU3)(_C!'X.E3Q,!!)&"'LB)R4S_QNJO+2E92I M6<\9.*K"W="4<2B5NB")DAG*BJ4@)DBK@H)$VJP]!^.OF)TU^C'K+TXZW3JF MU6>9+L'SCGM>'L`9&$=]/^H'I]>>C];MB[58;='4FETLJ[2X M-`:5`1'(HY`QZ`\<\L<*YJ!.9PUD2MY'KK:>4K4K)5>2;23)E-I(-W2D:X61 M.8I7:;=TF8Q0WV[NH[]-=];B%;M.XR;=>Y#I=9/<&M!FVP_#X?D&JY<0X-(Q,6@O8I:"K@8J8W M:&X@/Y!J`>KBUV`'$\8G`6+?6+OML/[O]&J;ZF4QXEDXDIV>N`:XG+P\XN`X M#Y#^SS#58J'Z2/"F?#NB#QH"YXP$^WEO^8:D=.E-"N<$]<3`+#O_``'\^FI? M.:O9$"#%#*=NWRB.XAX"'3<=M5&O8X@*A,1:`54@$14I^[?H(;?[-1U,UF6# MXQPBFQVMNI$QB_48FCR1)9BA/ M]=4)]NG;*M+=N,++([5H85+QXG!P/'XECS[[D`BFSFN+*%!RT(T M[E"C_=.'AKPTNU-C6C:M/FX76Z3;C.EV MLJQC%48A%YY1L)[7O,3-O(I/DOC;DVK1([-G'3-TCC*8C:81RP9NH5&)CW\; M-`REE3/_`$9599<43B4`,D4OGOK'>I&SK38WT5?MQLQ]LGREUH2U4R5$6/?M MR\SIVMERF-$P*BD#'@F,;R\J>0$!QDX_92SM.-U9*-QM4Y.RN(UD)3NW@L6Y MSIM42]VP*+*`!0WZ`(]>FL*VY9GWNZRZ%P+6.)4]@C(+A7R9%$Z:7L#TR4+$ M0]4R_P"]9EN@1.=J37.(53I5J@FMQK6.+%8++(6@\`_9A)1S60L,<`P;23<, M5"=^W>9[/"<#!W_&^?;7CT]5BE&H_IJ*BV$.L MUC5W"*IB20D=.%NQSL'JDV^`ZLW5?:=GV[<:4;?!=1S:=I)'B&I,5/[V.(]@ MC(=OWV;73YDFK>T!C`0I`Q5(EPFY5G%PTE)NG"":#)@[Q0QW$YLF2Q,D.+@=0"'$C%8\R&/\[\_LGP_,2I MGURLY*QU5*C?8Z>IK/2:?/G;1O#0SRG*=#\LD" M8M/KQX1Y]X;RW?77JHVSOIS&7ZDFX*@):$X+D1Q]43GV-M$RT'*Q^8QP*!I)5I!& M`Q3G&+UQHZ^G,HSI84?O#[X@>QQP']RGB5&26,>&'++!#[CT%AGK'1:QFVC6 M"1M5/;V>4<3+Z&1FZM(-V,Q&MW[I04E%"`J)!#<1$-;QK=]=/]QRV5NY+;4_ MG98&S'MU!ITC2U`"#@,$([8PYEOO-&WY>WS)#J5IP)9(ROW,XD`Y"B&^W3QUX)=QZ2/`8ZDJV/>0` M5<<5'!>79![+ZP+4ODAG^DA?8>41IY):T#E5P0]S57)O#_!%%YF<8U+5`WZY M4*I0S]&Q3#J"+9D;[6[$#,\L166BP4.H5105TS!U'SULBD:W;&^[7)I*^;-V M[54Y+6/<"6$L*-(0$8HBA5PBQ5AD^6\SF+-`50O(_:D3!<-.%G`/*/%3CU?D MN,''BR&M&(:%+.99SCFGOG6`%P`!/A/(81DVW*2TW*WRIE26.F\M6/L,1]^X-ACB M!Q:1M>74.+>&7=8HI(]PVJ,1CRI-6MCE'T@VC8J$,L:.])LG(R;M,BBAA!,J M9A$=III><"`6)JP.G'!>:X1T162.G>U>D%1>:BD ME3K[-!:I*DXZ6A%_#EK'S_P`%BT5H6(>%V.(\$"Y!3P5C@+!`JE7=1Q)0 M[$)R*:MZHO8CM$"D,L/]-54`+WB`:Z)W14=%[[U$D[6W'-N@Z MV/?[-THVO7_E$_SYLYK`2\ZD`(7@!CS6-84$_<]0'O9Y85V+B0AQQ0JD6\E> M1GN]\,L/6[.F;[7Q`G*C6F)6[:NT]C>BVJ?LLVX0B*Q%Q/W%PDT`59AXD*H& M`XF3`2E#N$-4-O6?IKN*LF4TADYLAC2[S$=I0<23@(\]PKKS2NTMF>,\%"^J M/C9CY;>[3Q%A<$Y@Y&/^,#[#F0LNXEH-R3I\;=$INK161I9JU<2DHZEUDHUF M$>W6,F(B8"%6$@C\H#O7HMN=-[]\[;;4#^8T[#H<25<1A@#@<>0Q&,4OS?<- M)22YM2]&$GXD!S[<8](,?+-'[1L];NF[ANY13726271.0Z:Q$U"&`Q#&`0$I M@'?P$-<_S:"JD5/3D5I9R[9B986S%@)U#($**J MQ@*!?/6U-B;1V_5[8K;Y?@X-IWG#$*`A*#,N(4`>R,4O5XJI,\,I%X8GY*9);8DB;GAAW86QJWTQTU#I%,)>@B(;ZMLG:FQ=WV2MK=JETNX4+"X-)/B1]-R@(_P#'2ZD*?_B$Z%$-]]]_`0#? M6B1+FXF8Q'JF4;!;.IQ)#P]FCGJ">^.+[K&^H*7W!CW@<$Q+]6W[@4$@J%3$ MOJ;@6M+E3[(_6G[.\D4 M=EO<'YTF2,)>],,L]O>`#OMW$9`8H[AT'5(]79R86ZW_`/0(N(VY.7^;&<,; M>UCA;$^-:U>\Q<>YV>W-M%3+E5=`T^!LS\/<>79[8M59MJF<\SY>#\ MQW\#ZXP!-^RC6[G$OZS?N;G-ZWU":;J,;!6);+QU(V1KTOV\PF;.T M3"0X!UV'IK()76&XTQU4=#0L?S#/V,6\;5GU8_J9IT_MVQRQOLAXMKTWO;Z*(^SI(EW*FHIR. M)"L`3U?MSCTMVG)D^.GF(\X'N_SCF=>S)$S*+B.L_.KG3.P,BD+.8A5,TO&1 M9.-4`2N&"CYFV(Y;I.$QV$R0E,&_CKSNZNU0!,J@H&3$*.#0K3P<.T'&*GZ: MF."/FG0<^[C'V[)[)7%I*2K\_@FWYJXK6.'JT13I.7P-D21JHW.*A$P28O;N MR_KL[)8A3W!:17(+M<3"8QA$1UXJ;JU?\[F9%9BO\1HP[HD?M"A'\B=,`[X^ M.?V<1.!DUN?_`#L414'^NA_C`H5-1,0^=,O_`"0]G=\>HZN']UYAEN:RTT(+ MG`Z@$.$3,VQ,8S2R<2WFR).Y-D[#=TS<&UB4EII,B@24:U$\:F!2K)$$3B;\-:QZPWZJZCV.JIJVFEME&A?+# M&JCL,NU4!]$9AL1TW:F[:&\%YZ3,>TZ97BP[$'+L[8Z'^I3II8+_S,8\$Z"92`JHP MEBM'8@)041V$P@)=_'7T^D]9_,::RDMMO(?D=.$TXAH,%(3D%?W;%+&4=SSEU'"5N4JG]-)N4 M$R%`NL.NV];U>KTR[3M$F9(<"S0$#4*A/9FJQ?9-HH),@RIK`XN:0I[0D:&L MO9+QS2OJ8C#?+/F)AFA"]>O83&]'RX[1J54*\64='CJXTYLJ1-D@?*M<`"7#4B>@"/7EB#%N/,)XUJ&*\45V.JN/Z-$-Z]6:]$%3(RCF M3'=,Q`[>XRCI1;O.NHH(J*K&,UZZNU,$ ML[36@`8NRO,>$3(PE))%)#P[$Y_;'FJ++3SZH5!X1M-F[`^+^1.+K1AK+U4C;AC^WQYX^8@GR/:EV= MO_+.F*R8E682$>L!56RZ1BJ(*D*8HAMK'K)=+E9ZP72G<&5BJ>*IS7-1G%2Y M4%+7TXI'-Q&1B+1K[,->@6Z$13><7.:J5IB3T(>O-LV/Y!&)9E*0B+%N^D&R MKU5L@FF`$!0QA*`:V6.K=66K,M%',J0,7D8G[,\8L\O:(9*\N7,3%8[_`(4] MHO&&)\_XUY*V+D!R6S9DG%"=F0IQ\MY)<62#CTK3#FA'R80XM4D-TVRAC$-O MW>H._ATUY+OU/N5TLC[**.GD29Q5V@(G/V14E;7=*G-F&:?"X'U%><;E9KXC MXUSSE?CIF*YN[*A:>,EVF;]C]"(E3,HEW-S=>=UMTG8V7I*!)LDV3PQB$`Q! M!4`'?RUB%DW3<+):JZSTZ?+5@1Q*JG9S[HO-1::6?4BI=\0,?&YC<+L5\U\; MP^/LFNK1`.*K;H6^T:[T29/7+M2;C7U#*1DW7IE)-51JLGZABG+L)5"&V'4- MF;HN&S*Y]12`3),P(]C@=)!YI%"\VEMSE"6TZ2.,:)__`(ZNBB`F]P+G8`AV M%`3Y@5,40(':&Y2M"@80`>F_3?6>?W<#9A:RS4;FG%4.<6JEVO/9),ET\EO` M5<,8=I?A_:.F'9#0V*@4`\ MM0T@*>><3!H`2':`>7AJ#6-8W0T(V(IQBG:7;;;IOO\`GJ42I8&D#!5@?%G% M=@U4B""*"0H^(?QU`@%%X90+00ARB@)D`=P#KX>(_P"O43B5.<2"5+:5`Q[S M%>TOP_CIAV1'0WE%>TNVVW34$`X")QX3S9B?T/(L?D^D3V6T4 MY&>D:^A8YYQ$+F^F0;J+`HEZ*?2QX!`+!P.1B&IDH*0HC%-3QAR,7MV)[UE" ML9%GK$WG^**T]E*RTE"EO<@MJ=;>5I7^3Y*I,"?]E$FHF>C7BL:]*229-WK8 M[U,CA84R<\]9*>3M;:%QW+9I#9=2R3.F-+6JX.$M[@02N*A>4;`M-PK+S+$N MLG/>-`8`3DU$`0)@(WIL,E!YNSQP-+9*!!V&:QMG*^#;)R3KL-+_`$M37X^9 M1C(!>4?2+15=%D6UOVB21>[L*[.EVAW]HZQOZ9.L]%U#V92V^Y3O_P!'*E#S M-2!SG)BHPQ7LC!KO+=:;F:*P9>L0;(.+B]0@/K^Z,&X2O/N07C!^9:C5JW5/ZE/041VES M204XY]ZPU2S^'&,2T/EWFR9S`YOL#F;*\U9`S9RBJ.1L'WZGPU:XK8_P9C=3 M*-)Q=;J]=5ZK%2+B;>9`I<&F#U&Q/W<@XD9!)=HD@B0R-WI;977![OEY+G`# ME%`,GS9X;*4J'M;G%2O'X8"/0L-8?5&8MAL5VC.,@]CG[B1BR"FF?Z@IT M4"DNL74[<.[JW\EJJF8^T4Y;IE' M3I!:U.`7VQN8JZY%0RN-HBWS_(/$.$'G*3F/)Y!M6"Z/&R-XHIL@M!!!XF-&J>SU",G<:;KGY/ MG;FNEW6ZYJS/CV3<91EH>>+!/*'@["D8QLL+^B\K=.M=S8)M'.:X$'DX$'WQ7IJN=23!- MD%""OJQB,_D;Q6M3=RK=<2E<.G;,#.W$4U7*21,J`B<%8\!V]55,0``((AOY M#KA:Z=!]R=-MT3+_`+,)-`]ZHUC@@Y9IZ8\.[VU%^I15R#HJ6X\U[HUIA^?6 M6\;,EZY>HT\NO%!].#EVW4;3K$40!([9\V43$KL"B0`$3"(EVV`=MM=6=.=^ MS*Z5)I=Q,<*O)ZE"""@.7+&-4C=]=;)XIZQCW%B`XI]G*,'9`]Z7*]+%V6)Q MU4[`"8'%%:5^XQZA"F,`)@9-HH)#=O@8>F_D`:ZOV[L/;>XDF,JG`Z510H!* M9IEZ(RZ7O.WU-.QTMA;-)Q\0/#NB-/,/O1\XF<@].N^MI4/279ML9\Q53'SB`OBF-0)CD&CTQ>J M2?57`#Y>64/;S]$=4QAB'F'R1&/JK6LSD%6))XO(+Q2+-6-4FG4I(.962?R2 M*2!?43DI:17=.SJF`JJRICF^8=8YN+TL;F"$]IB?OB1[8;'%K:.ELBJMY.?`6YGI"@=9%FW2-ZA8N/4'8X`HJ/ MS65Q)H0X$`=@R^^-FW?K%2VRW/M>VY09+=*+05 M!Q=F[(9'(1,LP8H1Z"#-DF1!LV;IH))D#H1-(I$TR%$=QV*0NW4?+6:4M+*H MZ5E/*P8P`".9YM74550YT\ZGE23S),?N$IA#;N\QWW#?0G^4WT%O\8PIXRGI#Z7HBF%D[-P[^SZ`#*[]W_N M]/CK"3^D/F3Y>GYU<=.?[>V,.W%^G,?S#3\RH5,\L/9Z8CEO_O!MK*[-^<>=_P`6:C0G`<%'(QC]O&T]?\(N MU=H">^,[8P#VPOJ1_P`,3X^&2_\`D_:4XH)/??KZWK*B[`?_`$]?AK.I_P"K M?ESYGS'E)VY)C&R+3JTM_+UTJ(D?QE_A3]K_`/K3].?1[%^I^U"A]1W]H?\` M5[!ZWJ[>.^L/J,C\ROIBYUOYFO\`4:O*7T>S[8R<'9O\HCV_+_(`]FVW3MZ[ M;?LU+3^3Y(\A/+Q3UXQ99W\TKJ3V1SEV\MM]OSU4*Q69]D7ZEB>&D(:0AI"& ,D(:0AI"&D(:0C__9 ` end